Nisman, B <br/><br/>
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.  [electronic resource] 

 -  British journal of cancer  Jan 2008 
 - 77-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6604157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Adult<br/>Aged<br/>Antigens, Neoplasm--blood<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Large Cell--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Carcinoma, Squamous Cell--blood<br/>Female<br/>Humans<br/>Keratin-19<br/>Keratins--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Prospective Studies<br/>Survival Rate<br/>Treatment Outcome